Feasibility of Plasma-Methylated SFRP2 for Early Detection of Gastric Cancer

Gastric cancer (GC) is fifth most frequently diagnosed cancer and second leading cause of cancer in China. More than 80% of GC are diagnosed at an advanced stage due to low uptake rate of invasive screening method. The performance of methylated SFRP2 test was evaluated in 236 plasma samples, includi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Control
Egile Nagusiak: Miao, Jin, Liu, Yi, Zhao, Guodong, Liu, Xiaoyu, Ma, Yong, Li, Hui, Li, Shiming, Zhu, Yun, Xiong, Shangmin, Zheng, Minxue, Fei, Sujuan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7218304/
https://ncbi.nlm.nih.gov/pubmed/32379490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1073274820922559
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak